-
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of "Hold" by Analysts
Source: Buzz FX / 09 Jan 2025 08:31:13 America/New_York
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Recommendation of "Hold" by Analysts Written by MarketBeat January 9, 2025 Share Link copied to clipboard. Shares of Fulcrum Therapeutics, Inc. ( NASDAQ:FULC - Get Free Report ) have
Read more...